Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Bladder Dysfunction Reports
Published in: Current Bladder Dysfunction Reports 2/2014

01-06-2014 | Voiding Dysfunction Evaluation (C Gomez, Section Editor)

The Evaluation and Treatment of Adult Nocturnal Enuresis

Authors: Christopher James Hillary, Christopher Chapple

Published in: Current Bladder Dysfunction Reports | Issue 2/2014

Login to get access

Abstract

Nocturnal enuresis is less common in adults than in childhood and is a significant cause of social and psychological debility and distress to patients, who may delay seeking treatment for fear of stigma. There is often an absence of significant underlying anatomical or functional pathology in patients with isolated nocturnal enuresis. A careful clinical assessment including a frequency-volume urine chart, post-voiding residual, and video-urodynamic assessment will identify the most appropriate treatment pathway by casting light on underlying pathophysiological abnormality. This will help direct the appropriate use of therapy whether it is desmopressin to reduce dieresis or an anticholinergic directed at detrusor overactivity. There is currently debate over the benefit of behavioral modification therapy, alarm systems and recently the role of posterior tibial nerve stimulation therapy in adult patients suffering from nocturnal enuresis. Adult onset nocturnal enuresis can be a sign of chronic retention and warrants urgent urological assessment and treatment.
Literature
1.
Abrams P et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61(1):37–49.PubMedCrossRef
2.
Yeung CK et al. Characteristics of primary nocturnal enuresis in adults: an epidemiological study. BJU Int. 2004;93(3):341–5.PubMedCrossRef
3.
Koff SA. Enuresis, in Campbell's Urology P.C. Walsh, Retik, A. B, Vaughan, Jr, et al, Editor., W. B. Saunders. p. 2065.
4.
Buckley BS, Lapitan MC. Prevalence of urinary and faecal incontinence and nocturnal enuresis and attitudes to treatment and help-seeking amongst a community-based representative sample of adults in the United Kingdom. Int J Clin Pract. 2009;63(4):568–73.PubMedCrossRef
5.
Hellstrom AL et al. Micturition habits and incontinence in 7-year-old Swedish school entrants. Eur J Pediatr. 1990;149(6):434–7.PubMedCrossRef
6.
7.
Yeung CK et al. Urodynamic findings in adults with primary nocturnal enuresis. J Urol. 2004;171(6 Pt 2):2595–8.PubMedCrossRef
8.
Harrison-Woolrych M et al. Nocturnal enuresis in patients taking clozapine, risperidone, olanzapine and quetiapine: comparative cohort study. Br J Psychiatry. 2011;199(2):140–4.PubMedCrossRef
9.
Light JK. Continence mechanisms following orthotopic bladder substitution. Scand J Urol Nephrol Suppl. 1992;142:95–7.PubMed
10.
Zahariou A et al. The use of desmopressin in the management of nocturnal enuresis in patients with spinal cord injury. Eur Medicophys. 2007;43(3):333–8.
11.
Ekinci O et al. Nocturnal enuresis in sickle cell disease and thalassemia major: associated factors in a clinical sample. Int J Hematol. 2013;98(4):430–6.PubMedCrossRef
12.
el-Bahnasawy MS et al. Persistent and occasional nocturnal enuresis in orthotopic urinary diversion: is there a urodynamic difference? BJU Int. 2005;96(9):1373–7.PubMedCrossRef
13.
Goonewardena SA, Sivapriyan S. High pressure chronic retention: a life-threatening clinical entity. Ceylon Med J. 2005;50(2):71–3.PubMed
14.
Ahmed AF et al. Efficacy of an enuresis alarm, desmopressin, and combination therapy in the treatment of saudi children with primary monosymptomatic nocturnal enuresis. Korean J Urol. 2013;54(11):783–90.PubMedCentralPubMedCrossRef
15.
Caldwell PH, Nankivell G, Sureshkumar P. Simple behavioural interventions for nocturnal enuresis in children. Cochrane Database Syst Rev. 2013;7, CD003637.PubMed
16.
17.
Lin AD et al. Nocturnal enuresis in older adults. J Chin Med Assoc. 2004;67(3):136–40.PubMed
18.
Rittig S et al. Abnormal diurnal rhythm of plasma vasopressin and urinary output in patients with enuresis. Am J Physiol. 1989;256(4 Pt 2):F664–71.PubMed
19.
Stenberg A, Lackgren G. Desmopressin tablets in the treatment of severe nocturnal enuresis in adolescents. Pediatrics. 1994;94(6 Pt 1):841–6.PubMed
20.
Vandersteen DR, Husmann DA. Treatment of primary nocturnal enuresis persisting into adulthood. J Urol. 1999;161(1):90–2.PubMed
21.
Yucel S et al. Impact of urodynamics in treatment of primary nocturnal enuresis persisting into adulthood. Urology. 2004;64(5):1020–5. discussion 1025.PubMedCrossRef
22.
Burgu B et al. Prospective evaluation of factors affecting the response and relapse rates to desmopressin therapy in male monosymptomatic enuretic adults. Urology. 2009;74(4):915–9.PubMedCrossRef
23.•
Hajdinjak T, Leskovar J. Comparison of nocturia response to desmopressin treatment between patients with normal and high nocturnal bladder capacity index. Sci World J. 2013. doi:10.​1155/​2013/​878564. This study demonstrates that the effectiveness of desmopressin on nocturia is not dependant on the nocturnal bladder capacity index.
24.
Weiss JP et al. Desmopressin orally disintegrating tablet effectively reduces nocturia: results of a randomized, double-blind, placebo-controlled trial. Neurourol Urodyn. 2012;31(4):441–7.PubMedCrossRef
25.
Lose G et al. Clinical experiences with desmopressin for long-term treatment of nocturia. J Urol. 2004;172(3):1021–5.PubMed
26.•
Goldberg H, et al. Low-Dose Oral Desmopressin for Treatment of Nocturia and Nocturnal Enuresis in Patients after Radical Cystectomy and Orthotopic Urinary Diversion. BJU Int. 2013. doi: 10.​1111/​bju.​12598. A significant proportion of patients with neobladders respond to night-time dose of desmopressin.
27.
El-Bahnasawy MS et al. Clinical and urodynamic efficacy of oxybutynin and verapamil in the treatment of nocturnal enuresis after formation of orthotopic ileal neobladders. A prospective, randomized, crossover study. Scand J Urol Nephrol. 2008;42(4):344–51.PubMedCrossRef
28.
Jerlstrom T, Andersson G, Carringer M. Functional outcome of orthotopic bladder substitution: a comparison between the S-shaped and U-shaped neobladder. Scand J Urol Nephrol. 2010;44(4):197–203.PubMedCrossRef
29.
Hunsballe JM et al. Single dose imipramine reduces nocturnal urine output in patients with nocturnal enuresis and nocturnal polyuria. J Urol. 1997;158(3 Pt 1):830–6.PubMedCrossRef
30.••
Negro CL, Muir GH. Chronic urinary retention in men: how we define it, and how does it affect treatment outcome. BJU Int. 2012;110(11):1590–4. An overview of the management of chronic urinary retention in men. PubMedCrossRef
31.
Homma Y et al. Clinical guideline for male lower urinary tract symptoms. Int J Urol. 2009;16(10):775–90.PubMedCrossRef
32.
Abeygunasekera AM et al. Significance of recent onset nocturnal enuresis in adult men: a prospective study. Ceylon Med J. 2004;49(3):79–81.PubMed
33.
Congregado Ruiz B et al. Peripheral afferent nerve stimulation for treatment of lower urinary tract irritative symptoms. Eur Urol. 2004;45(1):65–9.PubMed
34.
de Oliveira LF et al. Transcutaneous parasacral electrical neural stimulation in children with primary monosymptomatic enuresis: a prospective randomized clinical trial. J Urol. 2013;190(4):1359–63.PubMed
35.•
Raheem AA et al. Role of posterior tibial nerve stimulation in the treatment of refractory monosymptomatic nocturnal enuresis: a pilot study. J Urol. 2013;189(1514). A novel treatment for nocturnal enuresis in adults.
36.
Fitzgerald MP et al. Nocturia, nocturnal incontinence prevalence, and response to anticholinergic and behavioral therapy. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(11):1545–50.PubMedCentralPubMedCrossRef
Metadata
Title
The Evaluation and Treatment of Adult Nocturnal Enuresis
Authors
Christopher James Hillary
Christopher Chapple
Publication date
01-06-2014
Publisher
Springer US
Published in
Current Bladder Dysfunction Reports / Issue 2/2014
Print ISSN: 1931-7212
Electronic ISSN: 1931-7220
DOI
https://doi.org/10.1007/s11884-014-0237-8

Other articles of this Issue 2/2014

Current Bladder Dysfunction Reports 2/2014 Go to the issue

BPH-Related Voiding Dysfunction (R Lee, Section Editor)

Relationship Between the Metabolic Syndrome and BPH-Related Voiding Dysfunction

Voiding Dysfunction Evaluation (C Gomez, Section Editor)

How to Best Predict Success of the Transobturator Male Sling

BPH-Related Voiding Dysfunction (R Lee, Section Editor)

Two-micron (Thulium) Laser Prostatectomy: An Effective Method for BPH Treatment

Voiding Dysfunction Evaluation (C Gomez, Section Editor)

Evaluation, Treatment and Management of Urinary Incontinence in Patients with Orthotopic Neobladder

BPH-Related Voiding Dysfunction (R Lee, Section Editor)

Future Pharmacotherapies for Male Lower Urinary Tract Symptoms

Hot Topic

The Mind-Bladder Connection: Current Understanding of the Relationship of Psychological Stress and Overactive Bladder Symptoms